24077351Gajjar A, Stewart CF, Ellison DW, Kaste S, Kun LE, Packer RJ, Goldman S, Chintagumpala M, Wallace D, Takebe N, Boyett JM, Gilbertson RJ, Curran TClinical cancer research : an official journal of the American Association for Cancer ResearchAnilides; Antineoplastic Agents; Cerebellar Neoplasms; Medulloblastoma; PyridinesAdolescent; Child; Child, Preschool; Dose-Response Relationship, Drug; Female; Humans; Male; Maximum Tolerated Dose; Receptors, G-Protein-Coupled; Smoothened Receptor; Treatment Outcome; Young AdultGajjar A, Stewart CF, Ellison DW, Kaste S, Kun LE, Packer RJ, Goldman S, Chintagumpala M, Wallace D, Takebe N, Boyett JM, Gilbertson RJ, Curran T. Phase I study of vismodegib in children with recurrent or refractory medulloblastoma: a pediatric brain tumor consortium study. Clin Cancer Res. 2013 Nov 15; 19(22):6305-12.Clin Cancer Res2013-09-27T00:00:002013Phase I study of vismodegib in children with recurrent or refractory medulloblastoma: a pediatric brain tumor consortium study.prns:hasAuthorListauthor listprns:hasNetworkhas networkprns:hasPublicationVenuepublished inprns:hasSubjectAreaMajorTopicListhas major subject area listprns:hasSubjectAreaMinorTopicListhas minor subject area listprns:informationResourceReferenceinformation resource referenceprns:maxWeightmaximum weightprns:medlineTAjournal title abbreviationprns:meshDescriptorUIMeSH DescriptorUIprns:meshSemanticGroupNameMeSH semantic group nameprns:minWeightminimum weightprns:numberOfAuthorsnumber of authorsprns:numberOfConnectionsnumber of connectionsprns:numberOfPublicationsnumber of publicationsprns:predicateNodepredicate nodeprns:publicationDatepublication dateprns:uniquenessWeightuniqueness weightprns:yearyearAcademic ArticleArticleDocumentbibo:pmidPubMed IdentifierAuthorshipvivo:hasSubjectAreahas subject areaInformation Resourcevivo:informationResourceInAuthorshipauthorsvivo:linkedInformationResourcelinked information resourcerdf:predicatepredicaterdf:typetyperdfs:labellabelConceptD008297Physiology11633280.54802MaleD008527Disorders490.985355MedulloblastomaD011725Chemicals & Drugs340.998351PyridinesD016896Concepts & Ideas826670.820931Treatment OutcomeAuthorship 14360.2416270.2416271authors10.2516has subject areaD020714Concepts & Ideas110.999719Maximum Tolerated DoseD043562Chemicals & Drugs770.995699Receptors, G-Protein-CoupledD055815Living Beings966650.815894Young AdultD000293Living Beings10621370.61882AdolescentD000813Chemicals & DrugsAnilidesD000970Chemicals & Drugs20570.947703Antineoplastic AgentsD002528Disorders240.996002Cerebellar NeoplasmsD002648Living Beings11632570.520082ChildD002675Living Beings10415030.693171Child, PreschoolD004305Concepts & Ideas38950.95931Dose-Response Relationship, DrugD005260Physiology11835990.534568FemaleD006801Living Beings12067970.397999Humans